Results 1 to 10 of about 27,587 (242)
The effects of neoadjuvant chemoradiotherapy-related frailty by analytic morphomics in esophageal cancer [PDF]
Background Neoadjuvant chemoradiotherapy followed by surgery offers potential cure for locally advanced esophageal cancer. Yet, frailty often emerges post-therapy, heightening risks of delayed surgery and complications.
Chien-Hung Chiu +10 more
doaj +2 more sources
Neoadjuvant chemoradiotherapy for resectable gastric cancer: A meta-analysis
ObjectivesTo evaluate the clinical curative effects and toxicity of neoadjuvant chemoradiotherapy for resectable gastric cancer compared to those of neoadjuvant chemotherapy.MethodsA systematic review and meta-analysis of the randomized controlled trials
Jiuzhou Chen +13 more
doaj +3 more sources
BackgroundThere is increasing evidence that neoadjuvant chemoradiotherapy is superior to neoadjuvant chemotherapy for patients with locally advanced gastric cancer. However, a number of studies have come to the opposite conclusion.
Youqi Zhu +13 more
doaj +1 more source
Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder [PDF]
Purpose: To assess the safety and efficacy of gemcitabine and cisplatin as neoadjuvant chemotherapy followed by selective bladder preservation chemoradiotherapy in muscle-invasive bladder cancer (MIBC).
Hyun Hwan Sung +8 more
doaj +1 more source
Background Neoadjuvant therapy favors the prognosis of various cancers, including esophagogastric junction cancer (EGC). However, the impacts of neoadjuvant therapy on the number of dissected lymph nodes (LNs) have not yet been evaluated in EGC.
Qi Wang +4 more
doaj +1 more source
Programmed death 1(PD-1) blockade has shown promising efficacy in advanced gastric cancer. Here, we performed a retrospective analysis of three patients with locally advanced gastric cancer who received adjuvant PD-1 plus chemoradiotherapy as neoadjuvant
Jia Wei +12 more
doaj +1 more source
Background The failure rate after neoadjuvant chemoradiotherapy followed by surgery is approximately 34.6%–48% for resectable esophageal carcinoma. Pathologic complete response after neoadjuvant chemoradiotherapy is an important factor in predicting ...
Jinsong Yang +3 more
doaj +1 more source
The aim of the study was to compare functional results prior to and following neoadjuvant chemoradiation therapy.Materials and methods. An analysis of the functional results of a prospective clinical study was carried out.
A. B. Baichorov, A. O. Rasulov
doaj +1 more source
BackgroundPatients with lateral lymph nodes (LLNs) metastasis are not effectively treated with neoadjuvant chemoradiotherapy. This study aimed to compare the efficacy of three neoadjuvant therapeutic regimens, namely, chemotherapy, chemoradiotherapy, and
Xiaolin Pang +17 more
doaj +1 more source
Survival benefit of adding chemotherapy to intensity modulated radiation in patients with locoregionally advanced nasopharyngeal carcinoma. [PDF]
BACKGROUND:To evaluate the contribution of chemotherapy for patients with locoregionally advanced nasopharyngeal carcinoma (NPC) treated by intensity modulated radiotherapy (IMRT) and to identify the optimal combination treatment strategy.
Xuemei Ji +5 more
doaj +1 more source

